The Quantellect read.As of Nov 20, 2026, 14 active firms cover Nutrien Ltd: 9 rate it Buy or better, 4 sit at Neutral, and 1 rate it Sell or worse, a buy consensus. Targets are tightly clustered, $63.00 to $85.00, so the covering firms are broadly aligned. The average target of $76.11 sits 16% above the current $65.39. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.67 next quarter toward $5.11 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS14 active firms
Buy
Strong Buy00%
Buy964%
Neutral429%
Sell17%
Strong Sell00%
Based on 14 active firms as of Nov 20, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$76.11
+16.4% upside
Average target across 9 active firms as of Nov 20, 2026 vs $65.39 current
Highest Target$85.00
Average Target$76.11
Lowest Target$63.00
Detailed analyst forecasts for NTR
Showing 1–10 of 10 named analysts shown · 14 active firms in the rating projection
As of Nov 20, 2026, 9 of 14 active firms rate NTR a Buy (4 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
NTR EPS & revenue forecast
EPS · NEXT QUARTER
$0.67
Range $0.36 – $0.89 · 7 analysts · +31% YoY
Next period, 7 analysts expect Nutrien Ltd to earn $0.67 a share (range $0.36 – $0.89), versus $0.51 a year earlier. Full-year consensus is $4.74, growing to $5.11 the year after.
REVENUE · NEXT QUARTER
$5.8B
Range $5.7B – $5.9B · 7 analysts · -0% YoY
Revenue is expected to reach $5.8B (range $5.7B – $5.9B), -0.0% year-over-year. Full-year consensus is $27.6B, rising to $27.3B next year.
Top analysts covering Nutrien Ltd
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on NTR.
#1
Jeffrey Zekauskas
JP Morgan · Rank #114
Buy
$75.00+14.7% to target
Overall win rate
51%
+ Follow
#2
Michael Sison
Wells Fargo · Rank #197
Buy
$90.00+37.6% to target
Overall win rate
44%
+ Follow
#3
Benjamin Theurer
Barclays · Rank #209
Buy
$78.00+19.3% to target
Overall win rate
45%
+ Follow
#4
Kristen Owen
Oppenheimer · Rank #422
Buy
$108.00+65.2% to target
Overall win rate
27%
+ Follow
#5
Ben Isaacson
Scotiabank
Buy
$80.00+22.3% to target
Coverage
—
+ Follow
NTR stock forecast FAQ
What is NTR's average 12-month price target?+
The 9 active firms with a live target average $76.11 for Nutrien Ltd over the next 12 months, ranging from a $85.00 high to a $63.00 low, as of Nov 20, 2026.
Is NTR stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 14 active firms as of Nov 20, 2026, 9 rate it Buy or Strong Buy, 4 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for NTR?+
The Street-high target is $85.00 (RBC Capital), and the Street-low is $63.00 (Jefferies). The average of all 9 active-firm targets is $76.11.
How many active Wall Street firms cover NTR?+
14 active firms have a recognized rating on Nutrien Ltd as of Nov 20, 2026, and 9 active firms carry a live 12-month price target.
Who is the most accurate analyst covering NTR?+
Among analysts who currently cover NTR, Jeffrey Zekauskas of JP Morgan has the strongest overall Quantellect track record (Rank #114). Their current call is Buy with a $75.00 target.
What is Nutrien Ltd's projected EPS for next quarter?+
The consensus estimate is $0.67 per share (range $0.36 – $0.89) across 7 analysts. Full-year EPS is projected at $4.74, rising to $5.11 the following year.
How much revenue is Nutrien Ltd expected to report next quarter?+
Consensus revenue is $5.8B (range $5.7B – $5.9B). Full-year revenue is projected at $27.6B, growing to $27.3B next year.
Have analysts been upgrading or downgrading NTR lately?+
As of Nov 20, 2026, 9 of 14 active firms rate NTR a Buy (4 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their NTR calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.